Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Incidence of oral lesions in HIV-1-infected women: reduction with HAART.

Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves ME, MacPhail LA, Mulligan R, Greenspan JS.

J Dent Res. 2004 Feb;83(2):145-50.

PMID:
14742653
2.

Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.

Nicolatou-Galitis O, Velegraki A, Paikos S, Economopoulou P, Stefaniotis T, Papanikolaou IS, Kordossis T.

Oral Dis. 2004 May;10(3):145-50.

PMID:
15089923
3.

Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.

Ortega KL, Vale DA, Magalhães MH.

J Oral Pathol Med. 2009 Jul;38(6):489-94. doi: 10.1111/j.1600-0714.2009.00783.x. Epub 2009 Apr 28.

PMID:
19453845
4.

Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).

Greenspan D, Komaroff E, Redford M, Phelan JA, Navazesh M, Alves ME, Kamrath H, Mulligan R, Barr CE, Greenspan JS.

J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):44-50.

PMID:
11064503
5.

Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.

Revankar SG, Sanche SE, Dib OP, Caceres M, Patterson TF.

AIDS. 1998 Dec 24;12(18):2511-3. No abstract available.

PMID:
9875598
6.

Oral lesions in Brazilian HIV-infected children undergoing HAART.

Miziara ID, Filho BC, Weber R.

Int J Pediatr Otorhinolaryngol. 2006 Jun;70(6):1089-96. Epub 2006 Jan 6.

PMID:
16406081
7.

Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.

Eyeson JD, Tenant-Flowers M, Cooper DJ, Johnson NW, Warnakulasuriya KA.

J Oral Pathol Med. 2002 Mar;31(3):169-74.

PMID:
11903824
8.

Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).

Navazesh M, Mulligan R, Karim R, Mack WJ, Ram S, Seirawan H, Greenspan J, Greenspan D, Phelan J, Alves M; Oral Substudy of the Women's Interagency HIV Study Collaborative Study Group*.

Oral Dis. 2009 Jan;15(1):52-60. doi: 10.1111/j.1601-0825.2008.01456.x. Epub 2008 Nov 11.

9.

Effect of highly active antiretroviral therapy on frequency of oral warts.

Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS.

Lancet. 2001 May 5;357(9266):1411-2.

PMID:
11356441
10.

Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?

Ceballos-Salobreña A, Gaitán-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D.

AIDS Patient Care STDS. 2000 Dec;14(12):627-35.

PMID:
11119429
11.

Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.

Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CC.

AIDS. 2000 Mar 10;14(4):415-21.

PMID:
10770544
12.

Reduction of HIV-associated oral lesions after highly active antiretroviral therapy.

Aguirre JM, Echebarria MA, Ocina E, Ribacoba L, Montejo M.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Aug;88(2):114-5. No abstract available.

PMID:
10468448
13.

The significance and management of periodontal lesions in HIV infection.

Robinson PG.

Oral Dis. 2002;8 Suppl 2:91-7. Review.

PMID:
12164669
14.

The changing role of HIV-associated oral candidiasis in the era of HAART.

Patuwo C, Young K, Lin M, Pardi V, Murata RM.

J Calif Dent Assoc. 2015 Feb;43(2):87-92. Review.

PMID:
25868223
15.

Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor.

Rakotoambinina B, Médioni J, Rabian C, Jubault V, Jais JP, Viard JP.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):443-9.

PMID:
11511820
16.
17.

Prognostic significance of HIV-associated oral lesions and their relation to therapy.

Birnbaum W, Hodgson TA, Reichart PA, Sherson W, Nittayananta W, Axell TE.

Oral Dis. 2002;8 Suppl 2:110-4. Review. Erratum in: Oral Dis. 2013 Jul;19(5):531. Nittayannanta, S W [corrected to Nittayananta, W].

PMID:
12164643
18.

Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients.

Kerdpon D, Pongsiriwet S, Pangsomboon K, Iamaroon A, Kampoo K, Sretrirutchai S, Geater A, Robison V.

Oral Dis. 2004 May;10(3):138-44.

PMID:
15089922
19.

Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.

Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, Levine AM.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1245-52.

PMID:
15385731
20.

Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.

Rizzardi GP, Tambussi G, Bart PA, Chapuis AG, Lazzarin A, Pantaleo G.

AIDS. 2000 Oct 20;14(15):2257-63.

PMID:
11089613

Supplemental Content

Support Center